Results 81 to 90 of about 5,865,913 (286)

Postprandial Dysmetabolism and Non-Alcoholic Fatty Liver Disease in Relation to Type 2 Diabetes Mellitus and Cardiovascular Risk [PDF]

, 2007
Het aantal gevallen van “ouderdomssuikerziekte” (type 2 diabetes mellitus) neemt in de Westerse wereld snel toe als gevolg van veranderingen in leefstijl (verhoogde consumptie van vet- en energierijke voeding en verminderde lichaamsbeweging), en als ...
Schindhelm, R.K.
core   +5 more sources

Nonalcoholic fatty liver disease: A precursor of the metabolic syndrome [PDF]

, 2015
The conventional paradigm of nonalcoholic fatty liver disease representing the “hepatic manifestation of the metabolic syndrome” is outdated. We identified and summarized longitudinal studies that, supporting the association of nonalcoholic fatty liver ...
Marchesini, Giulio, Lonardo, Amedeo, MARCHESINI REGGIANI, GIULIO, Loria, Paola, Angulo, Paul, Ballestri, Stefano   +5 more
core   +1 more source

Nonalcoholic Fatty Liver Disease-Related Chronic Kidney Disease

Canadian Journal of Gastroenterology and Hepatology, 2020
Nonalcoholic fatty liver disease has become the main concern of hepatologists around the world and the main research topic for identifying effective and safe therapy.
Camelia Cojocariu, Ana-Maria Singeap, Irina Girleanu, Stefan Chiriac, Cristina M. Muzica, Catalin Victor Sfarti, Tudor Cuciureanu, Laura Huiban, Carol Stanciu, Anca Trifan   +9 more
doaj   +1 more source

The Interactions of Nonalcoholic Fatty Liver Disease and Cardiovascular Diseases [PDF]

, 2014
A complex interaction among metabolic factors, adipose tissue lipolysis, oxidative stress, and insulin resistance results in a deleterious process that may link nonalcoholic fatty liver disease (NAFLD) with severe cardiovascular (CV) outcomes.
Poynard, Thierry, Perazzo, Hugo, Dufour, Jean-François   +2 more
core   +1 more source

Protocols for Mitochondria as the Target of Pharmacological Therapy in the Context of Nonalcoholic Fatty Liver Disease (NAFLD).

, 2021
Nonalcoholic fatty liver disease (NAFLD) is one of the most frequent metabolic chronic liver diseases in developed countries and puts the populations at risk of progression to liver necroinflammation, fibrosis, cirrhosis, and hepatocellular ...
Grattagliano I, Molina-Molina E, Shanmugam H, Garruti G, Di Ciaula A, Baj J, Wang DQ, Portincasa P   +7 more
core   +1 more source

Role of nonalcoholic fatty liver disease in hepatocellular carcinoma

Annals of Hepatology, 2009
Obesity and related disorders are a common cause of morbidity worldwide. Nonalcoholic fatty liver disease is the most important hepatic consequence of adipose accumulation.
Norberto C. Chávez-Tapia, Nahum Méndez-Sánchez, Misael Uribe   +2 more
doaj   +1 more source

Serum osteopontin levels as a predictor of portal inflammation in patients with nonalcoholic fatty liver disease

, 2013
Background: Osteopontin is a secreted phosphorylated glycoprotein that is expressed by a variety of cell types and that mediates numerous and diverse biological functions. Osteopontin knockout mice are protected from obesity-induced hepatic steatosis. In
ÖZEN ALAHDAB, YEŞİM, ATUĞ, ÖZLEN, EREN, FATİH, YILMAZ, YUSUF   +3 more
core   +2 more sources

Effect of Korean Red Ginseng in chronic liver disease

Journal of Ginseng Research, 2017
Chronic liver disease, one of the most common diseases, typically arises from nonalcoholic fatty liver disease, alcoholic liver disease, chronic viral hepatitis, or hepatocellular carcinoma.
Tae Young Park, Meegun Hong, Hotaik Sung, Sangyeol Kim, Ki Tae Suk   +4 more
doaj   +1 more source

Pediatric nonalcoholic fatty liver disease

Jornal de Pediatria, 2019
n ...
Chiesa Claudio, Andreoli Gian Marco, Pacifico Lucia   +2 more
openaire   +7 more sources

Nonalcoholic Fatty Liver Disease and Continuous Metabolic Syndrome in Adolescents with Overweight/Obesity

Acta Médica Portuguesa
Introduction: Nonalcoholic fatty liver disease is the leading cause of pediatric chronic liver disease. Although nonalcoholic fatty liver disease is closely associated with obesity, its relationship with metabolic syndrome in children is not fully ...
Sofia Ferreira, Joana Mendes, Daniela Couto, Dário Ferreira, Carla Rêgo   +4 more
doaj   +1 more source